Pinocembrin polymeric micellar drug delivery system: preparation, characterisation and anti-hyperuricemic activity evaluation

J Microencapsul. 2022 Aug;39(5):419-432. doi: 10.1080/02652048.2022.2096138. Epub 2022 Jul 15.

Abstract

Aim: Hydrophobic pinocembrin (PCB) was incorporated into a new nano-drug delivery system to enhance solubility, bioavailability and anti-hyperuricemic activity of the drug.Methods: We fabricated PCB loaded polymeric micelles (PCB-FPM) by thin film dispersion method and appropriately determined their physical characteristics. The oral relative bioavailability and anti-hyperuricemic activity of PCB-FPM and free PCB were observed.Results: The optimum particle size of the micelles was 19.90 ± 0.93 nm. PCB-FPM exhibited great stability within 18 days, coupled with lower cytotoxicity and higher biocompatibility. Moreover, the percent cumulative release of PCB-FPM was much higher than free PCB in the dissolution media. The oral bioavailability of PCB-FPM was increased by 2.61 times compared with free PCB. Uric acid (UA) level of rats was reduced in PCB-FPM group (200 mg/kg) by 78.82% comparable to the model control.Conclusion: PCB-FPM may become an ideal strategy to increase oral in-vivo availability and anti-hyperuricemic activity of PCB.

Keywords: Pinocembrin; anti-hyperuricemic activity; oral bioavailability; polymer micelles.

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Drug Carriers / chemistry
  • Drug Delivery Systems* / methods
  • Flavanones
  • Micelles*
  • Particle Size
  • Polymers / chemistry
  • Rats
  • Rats, Sprague-Dawley
  • Solubility

Substances

  • Drug Carriers
  • Flavanones
  • Micelles
  • Polymers
  • pinocembrin